Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Germany would share Europe-only COVID vaccine with Israel, citing ‘special relationship’

(JTA) — Germany has pledged to include Israel in Europe’s deal for a future vaccine against the COVID-19 virus, in keeping with Germany’s “special relationship” with Israel as a response to the Holocaust.

According to Israeli media, German Foreign Minister Heiko Maas and Health Minister Jens Spahn made the commitment to Israel’s Foreign Minister Gabi Ashkenazi and Israel’s Ambassador to Germany Jeremy Issacharoff in conversations on Oct. 11.

A Ynet report claims Germany used its influence on the E.U. to bend the rule that a European-produced vaccination would be given first to European countries. Germany justified the decision in part through its historical commitment to support Israel.

Embassy spokesperson Shir Gidon told Globes, the Israel business news service, that “Germany sees Israel as part of Europe in terms of procuring the vaccine and therefore it will be permitted to convey the vaccine for use in Israel when it is approved.”

The decision, which followed an earlier meeting between Ashkenazi and Maas in Berlin, would allow Israel — an associate member of the European Union — to purchase some of the 400 million vaccines that the U.K.-Swedish company AstraZeneca is contracted to produce for the E.U., if the vaccine, currently in currently in phase III human trials, is found to be safe and effective.

Ashkenazi told Ynet that an eventual vaccine would “allow the economy to return to full activity in Israel,” and thanked Issacharoff and the embassy staff for their role in reaching the agreement.

In 2008, German Chancellor Angela Merkel, as the first in her position invited to speak to the Knesset, described Germany’s “special historical responsibility for Israel’s security” as part of Germany’s “raison d’être.”

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version